Going anti-Viral
Introducing Going anti-Viral, the podcast of the IAS–USA, a professional continuing medical education organization focused on HIV and other viral diseases. I’m Dr Michael Saag, professor emeritus of medicine and infectious diseases at the University of Alabama at Birmingham and volunteer member of the IAS–USA Board of Directors.
Join us as we interview experts in viral medicine about their area of specialty and current developments in the field. Other episodes are drawn from the IAS-USA vast catalogue of panel discussions, Dialogues, and various meetings and conferences.
Going anti-Viral is a podcast series for clinicians, produced by the International Antiviral Society–USA. The IAS–USA is a not-for-profit professional organization committed to improving the treatment, care, and quality of life for people with or at risk for HIV or other viral infections and their complications through balanced education and information. This podcast is intended as a clinical source of information for specialists in this field, but we hope anyone listening will enjoy learning more about the state of modern medicine around viral infections and their consequences.
Episodes
78 episodes
Management of Hepatitis B Virus Infection and Vaccination – Dr Debika Bhattacharya
In episode 77 of Going anti-Viral, Dr Debika Bhattacharya joins host Dr Michael Saag to discuss the management of hepatitis B virus (HBV) infection and vaccination. Dr Bhattacharya is a Clinical Professor at the University of Californi...
The Impact of Long-acting Injectable HIV Treatments on Public Health – Dr Kelly Gebo
In episode 76 of Going anti-Viral, Dr Kelly Gebo joins host Dr Michael Saag to discuss the impact of long-acting injectable HIV treatments on public health. Dr Gebo is Dean of the Milken Institute School of Public Health at the George ...
Cognitive Aging in HIV: Clinical Assessment and Management – Dr Shibani Mukerji
In episode 75 of Going anti-Viral, Dr Shibani Mukerji joins host Dr Michael Saag to discuss a presentation she gave at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) entitled Cognitive Aging in HIV: Clinica...
Immunology of HIV Cure and Beyond: Navigating Immunology Presentations at CROI 2026 – Dr John Frater
In episode 74 of Going anti-Viral, Dr John Frater joins host Dr Michael Saag to discuss a presentation he gave at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) entitled Immunology of HIV Cure and Beyond: N...
Special Episode - Latest Update on Emerging Infections and Health Threats
In episode 73 of Going anti-Viral, we represent a panel discussion from March 26, 2026, as part of the IAS–USA Dialogue series Emerging Infections and Health Threats. This Dialogue is a must listen as our distinguished panel o...
Neurodegeneration and Dementia Risk in Older Adults with HIV: Biomarkers and Epidemiology – Dr Alan Winston
In episode 72 of Going anti-Viral, Dr Alan Winston joins host Dr Michael Saag to discuss a presentation he gave at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) entitled Neurodegeneration and Dementia Risk...
CROI 2026 Review: What’s New, What’s Next in HIV Research – Dr Peter Hunt
In episode 71 of Going anti-Viral, Dr Peter Hunt joins host Dr Michael Saag to provide a review of the science presented at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI). Dr Hunt is a Professor of Medicine at ...
From Wall Street to ACT UP: A Life Rewritten by HIV - Peter Staley
In episode 70 of Going anti-Viral, Peter Staley joins host Dr Michael Saag after giving the Martin Delaney presentation at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) entitled ''Annus Horribilis" and The...
Successes in HIV-1 Vaccine Design: Accelerating Completion of One of Sciences’ Most Difficult Vaccines – Dr Kevin Saunders
In episode 69 of Going anti-Viral, Dr Kevin Saunders joins host Dr Michael Saag to discuss a plenary presentation he gave at the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) entitled Successes in HIV-1 Vaccin...
Strategic and Resilient Responses to the Funding Crisis Across Africa – Dr Ruanne Barnabas
In episode 68 of Going anti-Viral, Dr Ruanne Barnabas joins host Dr Michael Saag to discuss topic of a symposium session at the upcoming the Conference on Retroviruses and Opportunistic Infections (CROI) entitled Strategic and Resi...
Reflections on a Career of HIV Medicine, Mentorship, and Scientific Legacy – Dr Martin Hirsch
In episode 67 of Going anti-Viral, Dr Martin Hirsch joins host Dr Michael Saag to discuss his career in HIV medicine, mentorship, and his scientific legacy. Dr Hirsch is a Professor Emeritus at Harvard Medical School and was Director o...
Preview of the 2026 Conference on Retroviruses and Opportunistic Infections (CROI)
In episode 66 of Going anti-Viral, Dr Nicolas Chomont joins host Dr Michael Saag to provide a preview of the 2026 Conference on Retroviruses and Opportunistic Infections (CROI). Dr Chomont is Chair of the Scientific Program Committee f...
IAS-USA Lifetime of Leadership Award – Dr Gerald Friedland
In episode 65 of Going anti-Viral, Dr Gerald Friedland joins host Dr Michael Saag as the recipient of the IAS–USA Lifetime of Leadership Award, established nearly 15 years ago to honor individuals whose contributions have left a profou...
Going anti-Viral 2025 – The Remarkable Outcomes of Scientific Research
In episode 64 of Going anti-Viral, we look back at the past year and beyond to share highlights from past episodes of the Going anti-Viral Podcast. In this selection of highlights, we share the remarkable outcomes of scientifi...
The Role of Outcomes Research on Clinical Decisions for Patient Care – Dr Mari Kitahata
In episode 63 of Going anti-Viral, Dr Mari Kitahata joins host Dr Michael Saag to discuss the role of outcomes research on clinical decisions for patient care. Dr Kitahata is a Professor of Medicine at the University of Washington (UW)...
The COVID-19 Pandemic and the Current State of Public Health in the US – Dr Rochelle Walensky
In episode 62 of Going anti-Viral, Dr Rochelle Walensky joins host Dr Michael Saag on World AIDS Day 2025 to discuss her experience as the Director of the Centers for Disease Control and Prevention (CDC) during the COVID-19 pandemic an...
The Evidence for Vaccine Safety and Effectiveness – Dr Yvonne Maldonado
In episode 61 of Going anti-Viral, Dr Yvonne Maldonado joins host Dr Michael Saag to discuss the evidence for vaccine safety and effectiveness. Dr Maldonado is a Professor in the Stanford University School of Medicine where she has ach...
Medical Cannabis: Evidence and Insight with Dr Donald Abrams
In episode 60 of Going anti-Viral, Dr Donald Abrams joins host Dr Michael Saag to discuss medical cannabis. Dr Abrams is a professor emeritus at the University of California San Francisco and a specialist in integrative oncology at the...
The CDC without Scientific Leadership - Dr Demetre Daskalakis
In episode 59 of Going anti-Viral, Dr Demetre Daskalakis joins host Dr Michael Saag to discuss his career in public health and the turnover in leadership at the US Centers for Disease Control and Prevention (CDC). Dr Daskalakis is an i...
Demystifying Syphilis: Diagnosis and Treatment – Dr Khalil Ghanem
In episode 58 of Going anti-Viral, Dr Khalil Ghanem joins host Dr Michael Saag to discuss current challenges in the diagnosis and treatment of syphilis. Dr Ghanem is a Professor of Medicine in the Division of Infectious Diseases at Joh...
A Personal Journey with HIV and Advocacy for HIV Research – Dawn Averitt
In episode 57 of Going anti-Viral, Dawn Averitt joins host Dr Michael Saag to discuss HIV advocacy and the importance of scientific research. Ms Averitt is a social justice advocate and founder of organizations focused on women with HI...
The Management of Cardiovascular Health in Patients with HIV – Dr Steven Grinspoon
In episode 56 of Going anti-Viral, Dr Steven Grinspoon joins host Dr Michael Saag to discuss managing cardiovascular health in people with HIV. Dr Grinspoon is a clinician in the Neuroendocrine and Pituitary Tumor Clinical Center and f...
Navigating HIV Care with GLP-1 Receptor Agonists – Dr Darcy Wooten
In episode 55 of Going anti-Viral, Dr Darcy Wooten joins host Dr Michael Saag to discuss navigating HIV care with glucagon-like peptide-1 (GLP-1) receptor agonists. Dr Wooten is a Professor of Medicine in the Division of Infectious Dis...
Treating Substance Use Disorder in an Inpatient Setting - Dr Ellen Eaton
In episode 54 of Going anti-Viral, Dr Ellen Eaton joins host Dr Michael Saag to discuss the treatment of substance use disorder in an in-patient setting. Dr Eaton is an Associate Professor in the Department of Medicine and Division of ...
Update on Emerging Infectious Diseases – Dr George Rutherford
In episode 53 of Going anti-Viral, Dr George Rutherford joins host Dr Michael Saag to provide an update on emerging infectious diseases. Dr Rutherford is a Professor Emeritus of Epidemiology, Preventive Medicine, Pediatrics and History...